Intestinal failure–associated liver disease develops in 40% to 60% of infants who require
long-term total parenteral nutrition (TPN) for intestinal failure and 15% to 40% of adults on …

There are essentially 3 types of hepatobiliary disorders associated with parenteral nutrition
(PN) therapy: steatosis, cholestasis, and gallbladder sludge/stones. Reported prevalence …

BACKGROUND These Guidelines for Paediatric Parenteral Nutrition have been developed
as a mutual project of the European Society for Paediatric Gastroenterology, Hepatology …

Background and Aims Oxaliplatin (OXA) is one of the most common chemotherapeutics in
advanced hepatocellular carcinoma (HCC), the resistance of which poses a big challenge …

Phytosterols, components of soy-derived lipids, are among the proposed exacerbants of
parenteral nutrition–associated cholestasis (PNAC). We investigated whether phytosterols …

Short bowel syndrome (SBS) is a malabsorptive state occuring as a result of surgical
resection or congenital disease of a significant portion of the small intestine (1). The amount …

Since its introduction into clinical practice, parenteral nutrition has revolutionized the care of
premature neonates. Serum transaminase and bilirubin levels are commonly elevated in …

Parenteral nutrition liver disease (PNLD) develops in 40–60% of infants who require long-
term PN for intestinal failure. The clinical spectrum includes hepatic steatosis, cholestasis …

Jaundice in the neonate is common, usually secondary to unconjugated or indirect
hyperbilirubinemia, and is most typically not dangerous to the infant. However, even in the …

Short-bowel syndrome (SBS) is defined as a state of malabsorption after resection or loss of
a major portion of the bowel due to congenital or acquired factors. This article presents an …